About: Molecular mechanism of action of repurposed drugs and traditional Chinese medicine used for the treatment of patients infected with COVID-19: A systematic review

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Molecular mechanism of action of repurposed drugs and traditional Chinese medicine used for the treatment of patients infected with COVID-19: A systematic review Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Molecular mechanism of action of repurposed drugs and traditional Chinese medicine used for the treatment of patients infected with COVID-19: A systematic review
Creator	Huang, Shuang Zheng, Jin Bi, Xue Fong Tyng, Chee Herng, Jiunn Huan, Bu Kou, Lian Lawson, Fahcina Lee, Dexter Lem, Fui Na, Chin Opook, Fernandes San, Qi Ye, Fu Yuan, Da
Source	MedRxiv
abstract	The emergence of COVID-19 as a pandemic has resulted in the need for urgent development of vaccines and drugs and the conduction of clinical trials to fight the outbreak. Because of the time constraints associated with the development of vaccines and effective drugs, drug repurposing and other alternative treatment methods have been used to treat patients that have been infected by the SARS-CoV-2 virus and have acquired COVID-19. In this systematic review, we provide an overview of the molecular mechanism of action of repurposed drugs or alternative treatment medicines used to attenuate COVID-19 disease. The research articles or grey literature, including theses, government reports, and official news online, were identified from 4 databases and 1 search engine. The full content of a total of 160 articles that fulfilled our inclusion criteria was analyzed and information about 6 drugs (ritonavir, lopinavir, oseltamivir, remdesivir, favipiravir, and chloroquine) and 4 traditional Chinese medicines (Shuang Huang Lian Kou Fu Ye, TCM combination of Bu Huan Jin Zheng Qi San and Da Yuan Yin, Xue Bi Jing Injection and Qing Fei Pai Du Tang) were extracted. All of the drug treatment options depend on the ability of the drug to inhibit the proliferation of the SARS-CoV-2 virus by binding to enzyme active sites, viral chain termination, or triggering of the molecular pathway, whereas traditional Chinese medicine has a pivotal role in triggering the inflammation pathway, such as the neuraminidase blocker, to fight the SARS-CoV-2 virus. This review provides an insight to experimental validation of drugs and alternative medicine used for the treatment and control of COVID-19.
has issue date	2020-04-14(xsd:dateTime)
bibo:doi	10.1101/2020.04.10.20060376
has license	medrxiv
sha1sum (hex)	3d6be1a614abc307acec28612246d8d53650ccc1
schema:url	https://doi.org/10.1101/2020.04.10.20060376
resource representing a document's title	Molecular mechanism of action of repurposed drugs and traditional Chinese medicine used for the treatment of patients infected with COVID-19: A systematic review
resource representing a document's body	covid:3d6be1a614abc307acec28612246d8d53650ccc1#body_text
is schema:about of	named entity 'full' named entity 'drugs' named entity 'based' named entity 'The' named entity 'binding' named entity 'alternative' named entity 'list' named entity 'development' named entity 'emergence' named entity 'systematic review' named entity 'ANALYZED' named entity 'PATHWAY' named entity 'VIRUS' named entity 'DRUGS' named entity 'INSIGHT' named entity 'ACQUIRED' named entity 'MOLECULAR' named entity 'OUR' named entity '160' named entity 'ABILITY' named entity 'CHEMICAL' named entity 'ROLE' named entity 'SYSTEMATIC REVIEW' named entity 'CASE REPORTS' named entity 'RESEARCH' named entity 'TO INHIBIT' named entity 'VIRAL' named entity 'GREY LITERATURE' named entity 'REMDESIVIR' named entity 'ONLINE' named entity 'TRADITIONAL CHINESE MEDICINE' named entity 'CONTENT' named entity 'INFORMATION' named entity 'ALTERNATIVE' named entity 'EXPERIMENTAL' named entity 'EXTRACTED' named entity 'METHODS' named entity 'DISEASE' named entity 'STRUCTURE' named entity 'LOPINAVIR' named entity 'ALGORITHM' named entity 'PAI' named entity 'ARTICLES' named entity 'DRUG' named entity 'ABOUT' named entity 'REVIEW' named entity 'MOLECULAR PATHWAY' named entity 'drug' named entity 'The' named entity 'ability' named entity 'COVID-19' named entity 'studies' named entity 'Tang' named entity 'nucleotide analogue' named entity 'lung' named entity 'medRxiv' named entity 'remdesivir' named entity 'COVID' named entity 'Lonicera japonica' named entity 'signal transduction pathway' named entity 'monoclonal antibodies' named entity 'medRxiv' named entity 'COVID' named entity 'Zingiber officinale' named entity 'lopinavir' named entity 'adenosine triphosphate' named entity 'Chloroquine' named entity 'Chloroquine' named entity 'prophylactic treatment' named entity 'chloroquine' named entity 'Shanghai'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software